Jennifer Winkel, NNP

Octeta Therapeutics is a clinical-stage pharmaceutical company based in Kalamazoo, MI, dedicated to developing groundbreaking therapies for liver and metabolic diseases, with a particular focus on Nonalcoholic Steatohepatitis (NASH). With a strong emphasis on modifying metabolism, Octeta Therapeutics aims to provide innovative solutions for the treatment of NASH, a condition that has a significant impact on individuals' health and well-being.Generated from the website